These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7930491)

  • 1. A Brazilian experience of treatment-resistant depression.
    Moreno DH; Moreno RA; Calil HM
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 2():11-6. PubMed ID: 7930491
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
    Ries RK; Wittkowsky AK
    Biol Psychiatry; 1986 May; 21(5-6):522-6. PubMed ID: 3697440
    [No Abstract]   [Full Text] [Related]  

  • 3. ECT response in medication-resistant patients.
    Chandragiri SS
    Am J Psychiatry; 1997 May; 154(5):721-2. PubMed ID: 9137151
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuation of antidepressant medications before ECT.
    Hamner M; Huber M
    Convuls Ther; 1996 Jun; 12(2):125-6. PubMed ID: 8744175
    [No Abstract]   [Full Text] [Related]  

  • 5. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 6. [Depression treatment--then, now and in the future].
    Mårtensson B; Andersson G; Wålinder J; Agren H
    Lakartidningen; 2013 Feb 27-Mar 12; 110(9-10):493-5. PubMed ID: 23540034
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcome of treatment-resistant depression in older adults.
    Stoudemire A; Hill CD; Morris R; Lewison BJ
    Am J Psychiatry; 1993 Oct; 150(10):1539-40. PubMed ID: 8379561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
    Boerner RJ; Lühring F
    Psychiatr Prax; 2010 Oct; 37(7):350-2. PubMed ID: 20703987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic principles of the current therapy of depressive states].
    Grecu G; Grecu-Gaboş M; Ardelean M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1988; 33(3):161-70. PubMed ID: 2975031
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment-resistant depression].
    Schmauss M; Messer T
    Fortschr Neurol Psychiatr; 2010 Mar; 78(3):169-83. PubMed ID: 19736630
    [No Abstract]   [Full Text] [Related]  

  • 11. Ongoing needs in depression. Symposium highlights from the World Congress of Psychiatry held in August 1996 in Madrid, Spain.
    J Clin Psychiatry; 1996 Dec; 57(12):600-10. PubMed ID: 9019473
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of Axis II comorbidity in the management of patients with treatment-resistant depression.
    Thase ME
    Psychiatr Clin North Am; 1996 Jun; 19(2):287-309. PubMed ID: 8827191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on STAR*D: a summary and UK perspective.
    Cowen PJ
    J Psychopharmacol; 2009 Aug; 23(6):618-9; discussion 622-4. PubMed ID: 19395431
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation.
    Hamani C; Giacobbe P; Diwan M; Balbino ES; Tong J; Bridgman A; Lipsman N; Lozano AM; Kennedy SH; Nobrega JN
    Am J Psychiatry; 2012 Dec; 169(12):1320-1. PubMed ID: 23212066
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological and biochemical aspects of therapy-resistant depression.
    Leonard BE
    Int Clin Psychopharmacol; 1991 Jul; 6 Suppl 1():13-28; discussion 28-9. PubMed ID: 1757716
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium prophylaxis in American patients with unipolar disorder.
    Schou M
    Arch Gen Psychiatry; 1994 Jun; 51(6):502-3. PubMed ID: 8192553
    [No Abstract]   [Full Text] [Related]  

  • 17. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.
    Am J Psychiatry; 2000 Apr; 157(4 Suppl):1-45. PubMed ID: 10767867
    [No Abstract]   [Full Text] [Related]  

  • 18. Electroconvulsive therapy as a treatment for recurrent depression.
    Kellner CH; Pritchett JT; Beale MD
    J Clin Psychiatry; 1993 Nov; 54(11):441-2. PubMed ID: 8270592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Roadmap for therapeutic strategies of treatment resistant depression].
    El-Hage W
    Presse Med; 2016 Mar; 45(3):320-2. PubMed ID: 26970939
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.